“Yes, sometimes we can see things visually by looking at a part,” said Connor Callais, product manager at Hubbard-Hall.

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Bipolar I Disorder. According to GlobalData, Phase III drugs for Bipolar I Disorder have an 80% phase ...

VHX-896 is under clinical development by Vanda Pharmaceuticals and currently in Phase III for Schizophrenia. According to GlobalData, Phase III drugs for Schizophrenia have a 68% phase transition ...

It’s that time of the year when Wall Street’s top strategists gaze into their crystal balls and tell investors where they see the stock market heading in the year ahead. But predicting 2025 ...